Publications

Magdolenova Z, Bilaničová D, Pojana G, Fjellsbø LM, Hudecova A, Hasplova K, Marcomini A, Dusinska M. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit 2012 Jan 25.
Halamoda Kenzaoui B, Chapuis Bernasconi C, Guney-Ayra S, Juillerat-Jeanneret L. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem. J. (2012) 441, 00–00
Boland S, Guadagnini R, Baeza-Squiban A, Hussain S and Marano F Nanoparticles used in medical applications for the lung: hopes for nanomedicine and fears for nanotoxicity. Journal of Physics: Conference Series, in press
Burello E, Worth, AP. (2011) Theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology, DOI: 10.3109/ 17435390.2010. 502980 This was also reported on by the media http://www.rsc.org/chemistryworld/News/2010/July/26071001.asp
Dusinska M, E Rundén-Pran, SC Carreira, M Saunders (2011). In vitro and in vivotoxicity test methods Book chapter 4. In Adverse Effects of Engineered nanomaterials: Exposure, Toxicology and Impact on Human Health. Edited by Fadeel, Pietroiusti & Shvedova, 2011
Halamoda Kenzaoui B, Chapuis Bernasconi C, Hofmann H, Juillerat-Jeanneret L. (2011). Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. NanoMedicine (In press).
Magdolenova Z, Rinna A, Fjellsbø L, Dusinska M (2011) Safety Assessment of Nanoparticles. Cytotoxicity and Genotoxicity of Metal Nanoparticles In Vitro. Journal of Biomedical Nanotechnology Volume 7, Number 1, January, pp. 20-21(2) Publisher: American Scientific Publishers
Staedler D, Idrizi E, Halamoda Kenzaoui B, Juillerat-Jeanneret L.(2011) Drug combinations with quercetin : doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother. Pharamacol., in press
Cengelli F, Voinesco F, Juillerat-Jeanneret L. (2010) Interaction of cationic ultrasmall superparamagnetic iron oxide nanoparticles with human melanoma cells. Nanomedicine, 5: 1075-1087
Hussain S., Thomassen L.C.J., Ferecatu I., Borot C., Andreau K., Martens J.A, Fleury-Feith J., Baeza A., Marano F., Boland S. (2010) Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Particle and Fibre Toxicology, 7, 10.
Juillerat-Jeanneret L, F Cengelli (2010) Chapter 18. Polymer–Drug Conjugates. Targeted Delivery of Small and Macromolecular Drugs, Edited by Ajit S. Narang and Ram I. Mahato CRC Press 2010 Pages 481–511 Print ISBN: 978-1-4200-8772-7, eBook ISBN: 978-1-4200-8773-4
Dusinska M, LM Fjellsbo, L Tran, L Juillerat-Jeanneret, F Marano, S Boland, M Saunders, M Whelan, Ch Housiadas, K Volkovova, J Tulinska, LE. Knudsen, MR. Vilà, L Gombau, G Pojana, A Marcomini.(2009) Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. The Parliament Magazine’s RESEARCH European Research and Innovation Review, Issue 9, May 2009, p. 38.
Dusinska M, LM Fjellsbo, E Heimstad, M Harju, A Bartonova, L Tran, L Juillerat-Jeanneret, B Halamoda, F Marano, S Boland, M Saunders, L Cartwright, S Carreira, S Thawley, M Whelan, Ch Klein, Ch Housiadas, K Volkovova, J Tulinska, M Beno, K Sebekova, LE. Knudsen, T Mose, JV. Castell, MR. Vilà, L Gombau, M Jepson, G Pojana, AMarcomini(2009) Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST – EC FP7 project. J. Phys.: Conf. Ser. 170 (2009) 012039 (5pp)A
Dusinska M and NanoTEST consortium (Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, Heimstad E, Harju M, Tran L, Ross B, Juillerat L, Halamoda Kenzaui B, Marano F, Boland S, Guadaginini R, Saunders M, Cartwright L, Carreira S, Whelan M, Kelin Ch, Worth A, Palosaari T, Burello E, Housiadas C, Pilou M, Volkovova K, Tulinska J, Kazimirova A, Barancokova M, Sebekova K, Hurbankova M,Kovacikova Z, Knudsen L, Poulsen M, Mose T, Vilà M, Gombau L, Fernandez B, Castell J, Marcomini A, Pojana G, Bilanicova D, Vallotto D (2009) Testing strategies for the safety of nanoparticles used in medical application. Nanomedicine, editorial, Vol 4, No 6, Aug 2009, pp.605-607 (3).
Dusinska M and NanoTEST consortium.(2009) Safety of nanoparticles used in medical application. Development of alternative testing strategies for toxicity testing. Science and Technology,Public service review, issue 4, 126-127.
S Val, S Hussain, S Boland, R Hamel, A Baeza-Squiban, and F Marano(2009) Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: Need for multiparametric evaluation due to adsorption artifacts. Inhalation Toxicology; 21(S1): 115–122